期刊文献+

非小细胞肺癌表达p53蛋白与放疗敏感性 被引量:3

The Expression Levels of p53 Protein Correlate with the Responses to Radiotherapy in Non-small Cell Lung Cancer
暂未订购
导出
摘要 目的 :研究p5 3蛋白在非小细胞肺癌 (NSCLC)组织中的表达水平与放疗敏感性的关系。方法 :采用常规的 10 %甲醛固定 ,石蜡包埋标本 ,免疫组化分析p5 3蛋白的表达及其与放疗敏感性的关系。结果 :p5 3蛋白表达阳性率为 4 0 % (2 0 / 5 0 ) ,70 % (2 1/ 30 )的p5 3蛋白 (- )肿瘤放疗有效 ,而p5 3蛋白(+ )中仅 15 % (3/ 2 0 )有效 (P <0 .0 1)。结论 :p5 3蛋白可作为NSCLC放疗敏感性预测的参考指标。 Objective The aim of this study was to investigate the expression levels of p53 correlate with the rosponses to radiotherapy in non small cell lung cancer(NSCLC).Methods Immunohistochemical staining of formalin fixed,paraffin embedded tissue sections of NSCLC was performed using a monoclonal antibody against p53.Results p53 expression were 40%(20/50).85% of the p53(+)were low radiotherapy responserate while 70% of p53(-)were high radiotherapy response rate.Conclusions p53 may play important role in determining tumor radiosensitivity in NSCLC.
出处 《肿瘤防治杂志》 2002年第2期165-166,共2页 China Journal of Cancer Prevention and Treatment
关键词 非小细胞肺癌 表达 P53蛋白 放疗敏感性 carcinoma,non small cell lung p53 protein immunohistochemistry
  • 相关文献

参考文献3

  • 1[1]Namba H, Hara T,Tukazaki T, et al. Radiation-induced Gl arrest is selectively mediated by the p53-Cip 1 pathway in human thyroid cell [J]. Cancer Res, 1995,55(10) :2075 - 2080.
  • 2[2]Schwartz JL,Rasey J,Wiens L,et al. Functional inactivation of p53 by HPV-E6 transformation is associated with a reduced expression of radi-ation-induced potentially lethal damage [ J ]. Iht J Radiat, 1999,75 ( 3 ):285-291.
  • 3[3]Nylander K,Nilsson P, Mehle C, et al. p53 mutations, protein expres-sion and cell proliferation in squamous cell carcinomas of head and neck[J]. Br J Cancer, 1995,71 (4) :826 - 830.

同被引文献28

  • 1朴春姬,田梅,刘林林,杨巍,李修义1.辐射诱导表达载体pEgr-hTRAIL的构建及其对肿瘤细胞的体外诱导凋亡作用[J].吉林大学学报(医学版),2005,31(2):169-172. 被引量:7
  • 2Blot WJ, McLaughlin JK. Passive smoking and lung cancer risk: What is the study now? [J]. J Natl Cancer Inst, 1998,90: 1416-1425.
  • 3Mitsudomi T, Takahashi T. Genetic abnormalities in lung cancer and their prognostic implications [J]. Gan To Kagaku Ryoho, 1996, 23 (8): 990-996.
  • 4Michael B, Onyinye O, David S, et al. Participation of p53 protein in the cellular response to DNA damage [J]. Cancer Res, 1991, 51: 6304-6307.
  • 5Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation [J]. Ann N Y Acad Sci, 2000,910: 121-137.
  • 6Fujita T, Kiyama M, Tomizawa Y, et al. Comprehensive analysis of p53 gene mutation characteristics in lung cancinoma with special reference to histological subtypes [J].Int J Oncol, 1999, 15: 927-933.
  • 7Figueras J, Gene M, Catalan J, et al. Glutathione Transferase M1 and codon 72 p53 polymorphism in a north-western Mediterranean population and their relation to lung cancer susceptibility [J]. Cancer Epidemic Biomarker Prey, 1996, 5:337-342.
  • 8Wang YC, Chen CY, Chen SK, et al. p53 codon 72polymorphism in lung cancer patients: association wThoracic Surgerylung cancer susceptibility and prognosis [J]. Clin Cancer Res, 1999, 5: 129-131.
  • 9Kiyohara C, Otsu A, Shirakawa T, et al . Genetic polymorphisms and lung cancer susceptibility: a review [J].Lung Cancer, 2002, 37: 241-243.
  • 10Nielsen LL,Maneval DC.p53 tumor suppressr gene therapy for cancer[J].Cancer Gene Ther,1998,5(1):52.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部